XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Revenues - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Disaggregation of Revenue [Line Items]        
Revenues $ 9,085,826 $ 10,085,926 $ 27,432,376 $ 30,199,441
Sublease income 129,622 $ 155,025 408,535 400,524
Omeclamox-Pak        
Disaggregation of Revenue [Line Items]        
Revenues 0      
Grant        
Disaggregation of Revenue [Line Items]        
Revenues     $ 400,000 $ 300,000
New Product Development Funding        
Disaggregation of Revenue [Line Items]        
Revenues $ 200,000